The RPS7 antibody is a research tool targeting Ribosomal Protein S7 (RPS7), a critical component of the 40S ribosomal subunit involved in protein synthesis. RPS7 binds to 18S rRNA during ribosome assembly and plays roles beyond translation, including DNA repair, apoptosis, and cell cycle regulation. Studies link RPS7 dysregulation to diseases such as cancer, where it may act as an oncogene or tumor suppressor depending on context, and neurodegenerative disorders. The antibody is widely used in techniques like Western blotting, immunofluorescence, and immunoprecipitation to investigate RPS7's expression, localization, and interactions. Its specificity is often validated using knockout models or siRNA silencing. Research utilizing RPS7 antibodies has advanced understanding of ribosomopathies, viral infections that hijack ribosomal functions, and cellular stress responses. Both polyclonal and monoclonal variants exist, with selection depending on experimental needs. As ribosome-related pathways gain attention in therapeutic development, RPS7 antibodies remain vital for elucidating molecular mechanisms in both physiological and pathological states.